ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

VANI vs HSDT // GROSS PROFIT MARGIN

Vivani Medical Inc. (NASDAQ) VS. Solana Company (Class A) (NASDAQ) • 15-METRIC TALLY: VANI 0 — HSDT 4
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (VANI VS. HSDT) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC VANI HSDT SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE — 96.00% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -24.79% -11.27% -13.52 HSDT /fcf-yield <GO>
Operating Margin — -60.00% — TIE /operating-margins <GO>
Net Profit Margin — -60.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — 5.40% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 25.63 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 4/9 -1.00 HSDT /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 45.0 46.5 -1.50 HSDT /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 3.6x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $102.8M $146.5M -$43.7M HSDT /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR VANI REV HSDT REV VANI GROSS % HSDT GROSS % VANI FCF HSDT FCF
FY 2025 $0 $548.0K — 98.0% -$25.5M -$16.5M
FY 2024 $0 $520.0K — -11.9% -$21.3M -$11.0M
FY 2023 $0 $605.0K — — -$23.7M -$10.4M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
VANI // BETA —
HSDT // BETA —